Last Updated: 03/18/15
Last price: 68.13 Total volume: 104,462
SSB Stock Chart - 1 Month
SSB Stock Chart - 3 Month
SSB Stock Chart - 6 Month
SSB Stock Chart - 1 Year
SSB Stock Chart - 2 Year
AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...
Continue Reading
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...
Continue Reading
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...
Continue Reading
Understanding the Class Action Lawsuit Against Joint Stock Company Kaspi.kz Levi & Korsinsky, LLP has brought to light an important class action lawsuit concerning the Joint Stock Company Kaspi.kz (NASDAQ: KSPI). This initiative aims to provide legal recourse to investors who may have suffered due to alleged fraudulent activities that negatively impacted the company's...
Continue Reading
Verdafero Launches New Emissions Reporting Service Verdafero, a prominent player in sustainability solutions, has introduced an expanded service for emissions reporting that now includes comprehensive tracking and analysis of Scope 1, Scope 2, and Scope 3 emissions specifically for the hospitality industry. This innovative offering provides businesses in this sector with...
Continue Reading
Key Analyst Ratings for Prominent Stocks Wall Street analysts have recently begun covering some noteworthy companies, aiming to provide insights for potential investors. Analyst ratings can spark interest in stocks and guide buying decisions, especially when backed by thorough research. This article highlights the initiation of coverage on five significant stocks,...
Continue Reading
Repertoire Immune Medicines and Eli Lilly Announce Collaboration Repertoire Immune Medicines is excited to announce a significant strategic collaboration with Eli Lilly and Company, focusing on the development of tolerizing therapies to treat various autoimmune diseases. This partnership is set to leverage Repertoire's advanced DECODE™ platform, designed to pioneer T...
Continue Reading
Manhattan Associates Faces Lawsuit Amid Significant Losses A class action lawsuit has emerged against Manhattan Associates, Inc. (NASDAQ: MANH), a prominent player in software solutions for supply chain management and inventory operations. This legal action highlights concerns from investors who have experienced notable financial losses stemming from alleged...
Continue Reading